Background: New consultants consistently feel better prepared for the clinical rather than non-clinical aspects of their role. However, deficiencies in generic competencies have been linked to burnout and patient complaints. This study explored how higher specialty training prepares doctors for the transition to consultant in genitourinary medicine.
Results: New consultants felt less prepared for non-clinical aspects of their role. Prior practical experience was the greatest influencing factor in levels of preparedness, with increased responsibility and leadership driving deeper learning. Observation of others helped individuals develop a professional identity but also learn about the wider processes within their service. The learning environment positively influenced preparedness but highlighted a need for dedicated time to learn non-clinical aspects.
Conclusion: To ensure future trainees feel prepared for the non-clinical aspects of the consultant role, practical experience of non-clinical areas with high levels of leadership and responsibility within a supportive learning environment is essential.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385763 | PMC |
| http://dx.doi.org/10.7861/clinmed.2020-0085 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Global regulatory considerations and practices for tumorigenicity evaluation of cell-based therapy.
Regul Toxicol Pharmacol
December 2024
China Pharmaceutical University, Nanjing, Jiangsu, China.
Article Synopsis
- Cell-based therapies, which are considered "living drugs," are complex and their safety evaluation, particularly for tumorigenicity, is crucial due to risks posed by residual undifferentiated cells.
- Factors like the source, differentiation status, and administration methods affect the tumor risk associated with these therapies and must be considered thoughtfully during evaluations.
- There's a lack of global consensus on tumorigenicity assessment standards, with varying regulations and practices around the world, but there are efforts to clarify strategies and focus areas for evaluating tumorigenicity in cell-based therapies.
Objective: This paper investigated the effects of prenatal drug exposure (PDE), childhood trauma (CT), and their interactions on the neurobiological markers for emotion processing.
Method: Here, in a non-clinical sample of pre-adolescents (9-10 years of age) from the Adolescent Brain Cognitive Development (ABCD) Study (N = 6,146), we investigate the impact of PDE to commonly used substances (ie, alcohol, cigarettes, and marijuana), CT, and their interaction on emotion processing. From the Emotional N-back functional magnetic resonance imaging task data, we selected 26 regions of interests, previously implicated in emotion processing, and conducted separate linear mixed models (108 total) and accounted for available environmental risk factors.
Mentalizing, epistemic trust and interpersonal problems in emotion regulation: A sequential path analysis across common mental health disorders and community control samples.
J Affect Disord
March 2025
Research Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom; Anna Freud National Centre for Children and Families, London, United Kingdom.
Background: Emotion regulation is a crucial function implicated in multiple mental health disorders; understanding the mechanisms by which emotion regulation has such impact is essential. Mentalizing has been posited as a prerequisite for effective emotion regulation. The current study aims to examine the roles of epistemic trust and interpersonal problems in driving the association between mentalizing and emotion regulation, contrasting clinical and non-clinical populations.
View Article and Find Full Text PDFClinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries.
Front Pharmacol
November 2024
Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Science, Jagiellonian University Medical College, Kraków, Poland.
Objectives: The aim of the study was to assess the reimbursement policy for orphan drugs (ODs) in selected European countries in relation to the availability and impact of clinical evidence, health technology assessment (HTA) procedures and reimbursement decision-making.
Materials And Methods: A list of authorized ODs was extracted from a web-based registry of the European Medicines Agency, including information on active substance, Anatomical Therapeutic Chemical (ATC) classification code, and therapeutic area. A country-based questionnaire survey was conducted between September 2022 and September 2023 among selected experts from 12 European countries.
End of life care in paediatric settings: UK national survey.
BMJ Support Palliat Care
November 2024
Department of Health Sciences, University of York, Heslington,York, UK.
Objectives: To describe end of life care in settings where, in the UK, most children die; to explore commonalities and differences within and between settings; and to test whether there are distinct, alternative models of end of life care.
Methods: An online survey of UK neonatal units (NNUs), paediatric intensive care units (PICUs) and children/young people's cancer principal treatment centres (PTCs) collected data on aspects of service organisation, delivery and practice relevant to end of life outcomes or experiences (referred to as the core elements of end of life care) across three domains: care of the child, care of the parent and bereavement care.
Results: 91 units/centres returned a survey (37% response rate).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!